Elsevier

Brain Research

Volume 829, Issues 1–2, 22 May 1999, Pages 174-179
Brain Research

Short communication
Opioid receptor gene: cytokine response element and the effect of cytokines

https://doi.org/10.1016/S0006-8993(99)01364-5Get rights and content

Abstract

Previous studies demonstrated that cytokines regulate opioid and opioid receptor gene expression in neuronal and immune cells. The gene sequence analysis of opioid receptors revealed that μ-, δ- and κ-opioid receptor promoter regions contain potential cytokine response elements (NF-IL6 binding sites). It was postulated that the response elements present in opioid receptor promoter regions may have a role in the cytokine effects on opioid receptor gene expression through cis–trans interaction. The present study investigated whether cytokines have an effect on opioid receptor gene expression by cytokine-induced transcription factor, NF-IL6, using a number of immune cell lines which respond to cytokines. Further investigation was made to determine whether the potential cytokine response element DNA sequences on opioid receptor promoter region have functional significance which may be affected by the DNA context of the opioid receptor promoter in immune cell lines. Tandem repeats of conserved cytokine response elements of IL-6 gene fused to a heteropromoter SV40 were utilized as a positive control and expressed 2-fold increased promoter activity after cytokine stimulation. Transient transfection studies in time courses (24–72 h) and different dose treatments (100–500 U/ml for IL-6 and 50–200 U/ml for IL-1 α+β) were also carried out to investigate the possibility that the upregulated gene expression may be transient or cytokine-dose-dependent. Our data demonstrated that there was no significant cytokine-stimulated opioid receptor gene expression in immune cells tested. In addition, the cytokine response elements (NF-IL6 binding sites) in opioid receptor genes are not functional. These results contradict the previous reports in which cytokines modulated the expression of opioid and opioid receptors in neuronal and immune cells. The possible reasons regarding the different results were discussed.

Section snippets

Acknowledgements

This research was supported by NIH research grants DA-00546, DA-01583, DA-05695, KO5-DA-70554, and A&F Stark fund of the Minnesota Medical Foundation. The authors would like to thank Dr. Sabita Roy for her invaluable discussions and kindness in providing IL-1β for this work.

References (21)

There are more references available in the full text version of this article.

Cited by (13)

  • The paradoxical role of methionine enkephalin in tumor responses

    2020, European Journal of Pharmacology
    Citation Excerpt :

    However, in some conditions, cytokines and opioid receptors may appear irrelevant. Further experiments revealed that there was no elevated opioid receptor expression in human myeloma cell line U266 and macrophage RAW264.7 stimulated with IL-1 or IL-6 (Im et al., 1999). Although these cells are not tumor cells, it can be proven indirectly that MENK positively correlates with pro-inflammatory cytokines.

  • Basic fibroblast growth factor activates the MAPK and NFκB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes

    2007, Journal of Biological Chemistry
    Citation Excerpt :

    Human MMP-13 promoter construct and plasmid expression vector containing siRNA targeting Akt (Mu6pro-Akt1/2) and control siRNA plasmid construct (Mu6pro) were previously described (27, 29, 30). The p3xNFκBLuc plasmid construct, containing three copies of tandemly repeated NFκB response element sequences (5′-TTGGGCACTCCCTG-3′) of MMP-13 promoter region was achieved by placing the NFκB response elements of MMP-13 promoter region upstream of an SV40 promoter at the SacI site of the pGL3-promoter vector, which contains a luciferase reporter gene system (Promega) as described previously (31). Transient Transfection by Nucleofection (Electroporation)—Nucleofection methods were optimized for use with human articular chondrocytes by minor modifications of the instructions for the Nucleofector™ kit (Amaxa Biosystems) that have been described previously (18, 32).

  • Regulation of opioid receptor expression

    2002, Current Opinion in Pharmacology
View all citing articles on Scopus
View full text